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A recently recognized strategy for gene regulation involves
transcription of a non-coding RNA (ncRNA) transcript that
overlaps the gene targeted for regulation. In many cases, it
seems that it is the act of transcription itself rather than
the ncRNA transcript that mediates regulation. A paper in
this issue of the EMBO Journal shows one mechanism by
which these transcription events regulate transcription;
elongating RNA polymerases direct a set of regulatory
histone modiﬁcations that modulate expression of an over-
lapping gene.
A major surprise of the past few years has been the
discovery of signiﬁcant transcription activity across entire
eukaryotic genomes, showing a large class of ncRNAs that
are often rapidly degraded (Yazgan and Krebs, 2007). In a
number of cases, these ncRNAs have been found to regulate
gene expression. Most of these regulatory ncRNAs function
through RNAi-mediated pathways of gene repression.
However, some ncRNAs regulate gene expression in cis.
In these cases, the act of transcription itself, rather than the
RNA product of transcription, mediates regulation of an
overlapping gene.
The proposed mechanisms for regulation in cis include
promoter occlusion or transcriptional interference by RNA
polymerases transcribing ncRNAs (Yazgan and Krebs, 2007).
Other genes show regulated transcription start-site choice
from a single promoter, giving rise to either a coding tran-
script or an ncRNA (Jenks et al, 2008; Kuehner and Brow,
2008). A cryptic promoter that lies at the 30 end of the PHO5
gene and drives an antisense transcript is required for the
normal kinetics of PHO5 activation (Uhler et al, 2007).
Transcription of a series of ncRNAs upstream of the
Schizosaccharomyces pombe fbp1þ promoter is required for
its induction when cells are shifted to inducing conditions
(Hirota et al, 2008). Passage of RNA polymerase II through
the fbp1þ promoter during transcription of these ncRNAs
promotes the formation of open chromatin, allowing the
transcription factor access to the fbp1þ promoter during
induction.
At present, reports by Houseley et al (2008) and by
Pinskaya et al (2009) provide compelling evidence that
transcription of ncRNAs inﬂuences post-translational modiﬁ-
cations of histones that facilitate the repression of overlap-
ping genes.
Chromatin immunoprecipitation (ChIP) experiments car-
ried out by Houseley et al showed a surprising pattern
of Set1-dependent histone H3K4 trimethylation across the
well-characterized GAL1–10 gene locus (Figure 1). A signiﬁ-
cant peak of this histone methylation mark, normally asso-
ciated with the 50 end of transcribed genes, was found within
the 30 end of GAL10 when cells were grown in glucose
medium (GAL1-10 repressing conditions). These observations
led Houseley et al to identify and characterize a set of
ncRNAs that are transcribed from the 30 end of GAL10 across
the promoter region shared by the divergent GAL1 and GAL10
genes, which they named GAL10 ncRNAs.
Pinskaya et al observed that cells lacking Set1 induced
GAL1–10 expression more rapidly than wild-type cells when
cells were shifted to galactose medium, although the ﬁnal,
fully induced levels of GAL mRNA were unchanged. The
increased expression of GAL1–10 in set1 cells correlated
with TBP occupancy at the GAL1–10 promoter, suggesting
that Set1 regulates transcription initiation at GAL1–10.
Furthermore, an H3K4A mutant showed a similar induction
phenotype, indicating a role for H3K4 methylation in GAL1–10
induction. Subsequent experiments identiﬁed a set of ncRNA
transcripts similar to those reported by Houseley et al, which
they named GAL1ucut (GAL1 upstream cryptic unstable
transcripts).
Both groups mapped the GAL1ucut promoter to a location
in the 30 end of GAL10 near a pair of binding sites for the Reb1
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Figure 1 Model for ncRNA-based regulation of GAL1–GAL10
expression. Cells grown in glucose (repressing conditions) tran-
scribe an ncRNA, GAL1ucut, from the 30 end of GAL10. This directs
H3K4 methylation at the 50 end of the GAL1ucut and H3K36
methylation across the GAL1–10 locus. The Rpd3S histone-deace-
tylase complex is recruited to and represses GAL1–10 expression.
Subsequent deacetylation of histones at the GAL1–10 promoter
might inhibit the recruitment of TBP and RNA polymerase II either
directly or indirectly by inhibiting chromatin-remodelling events
that are necessary for the binding of these factors. The physiological
relevance of this mechanism might be to delay GAL1–10 induction
in the presence of galactose until all the available glucose is utilized.
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GAL10, abolished GAL1ucut expression. Furthermore, both
groups found an inverse relationship between GAL1ucut and
GAL1–10 expression. GAL1ucut is expressed under conditions
that repress GAL1–10, and as GAL1–10 is induced GAL1ucut
declines. Curiously, Houseley et al did not observe an effect
of GAL1ucut on GAL1–10 expression when cells were shifted
to a medium with high levels of galactose. Rather, they
observed that GAL1ucut antagonized the induction kinetics
and ﬁnal levels of GAL1–10 in a medium with low levels of
both glucose and galactose. The basis for the difference in
observations between the groups is not obvious, but both
agree that GAL1ucut is used to attenuate GAL1–10 expres-
sion.
Both groups argue that GAL1ucut acts in cis. First,
Houseley et al formed a heterozygous diploid yeast strain in
which one of the two GAL1–10 loci lacked the GAL1ucut
promoter. They observed no attenuation of GAL1–10 expres-
sion in this strain. Second, both groups found that GAL1ucut
RNA was stabilized by mutations affecting RNA degradation
pathways used to target ncRNA, and Pinskaya et al showed
that this stabilization had no effect on GAL1–10 induction.
Earlier work has shown that Rpd3S histone-deacetylase
complex is recruited to the body of protein-coding genes by
H3K36-methylated nucleosomes (Lee and Shilatifard, 2007).
This serves to inhibit intragenic transcription from cryptic
promoters that might otherwise be activated by the passage
of transcription elongation complexes. Houseley et al
observed that histone modiﬁcations, which are the hallmarks
of this Rpd3S-mediated intragenic repression mechanism,
methylation of histone H3K36 and subsequent histone
deacetylation, were found across the repressed GAL1–10
locus. Furthermore, these marks were dependent on
GAL1ucut transcription, and deletion of the Eaf3 subunit of
the Rpd3S complex relieved glucose repression to a level
similar to that observed when the GAL1ucut promoter was
deleted.
Pinskaya et al also found a role for Rpd3S in GAL1ucut
function. As H3K4-methylated histones can be recognized by
proteins with the PHD domain (Mellor, 2006), Pinskaya et al
systematically tested yeast strains lacking different PHD
proteins for an effect on GAL1–10 induction. They found
that loss of Rco1, a component of the Rpd3S complex,
mimicked the effects of set1 mutations on GAL1–10 expres-
sion. In addition, they used ChIP to show that Rpd3 is
recruited to the repressed GAL1–10 locus and that this is
abolished by H3K4A and set1 mutations. Interestingly, they
did not observe any effect of a mutation deleting SET2, which
encodes the H3K36 methyltransferase (Lee and Shilatifard,
2007), on GAL1–10 induction kinetics, suggesting that the
effects of GAL1ucut transcription might be mediated primarily
through H3K4 methylation.
Although the different observations regarding the effects of
GAL1ucut on induction kinetics and expression in low levels
of glucose still need to be resolved, these papers indicate that
cryptic transcription events might be used to set the chroma-
tin-modiﬁcation state of overlapping sequences. This regula-
tory strategy might be used more widely; both groups present
preliminary observations, suggesting that ncRNA might reg-
ulate expression of other yeast genes. Furthermore, in higher
eukaryotes, ncRNA are implicated in genomic imprinting
(Edwards and Ferguson-Smith, 2007) and the function
of some enhancers (Drewell et al, 2002). Perhaps these
transcription events serve to establish epigenetic marks that
inﬂuence the function of the overlapping regulatory
elements.
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